MedTrace Logo

INtegrating Systematic PatIent-Reported Evaluations in Multi-Disciplinary Tumor Boards: The INSPIRE Study

NCT07671937 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2748

Last updated 2026-07-02

No results posted yet for this study

Summary

The purpose of the study is to characterize baseline multidisciplinary tumor board (MDTB) context and variability, evaluate the relationship between baseline fitness of patients with cancer and initial treatment recommendations, and assess the impact of the INSPIRE intervention, which involves including electronic patient reported outcomes (ePROs) within MDTB on MDTB discussion content, provider burden, treatment recommended and received, healthcare utilization, and patient-reported outcomes.

Conditions

  • Breast Cancer
  • Corpus Uteri Cancer
  • Ovary Cancer
  • Pancreas Cancer
  • Other Female Genital Malignant Neoplasms

Interventions

BEHAVIORAL

INSPIRE (INtegrating Systematic PatIent-Reported Evaluations)

The INSPIRE intervention is the systematic capture and presentation of patient-reported outcomes (geriatric assessment, patient preferences, and distance to care) within multi-disciplinary tumor boards

BEHAVIORAL

Capture of patient-reported outcomes

Capture of patient-reported outcomes including geriatric assessment and patient preferences

BEHAVIORAL

Enhanced Clinician Awareness

Inclusion of patients within tumor board that may have patient-reported outcomes

Sponsors & Collaborators

  • University of Oklahoma

    collaborator OTHER

  • University of California, Los Angeles

    collaborator OTHER

  • Canopy Cancer Collective, LLC

    collaborator NETWORK

  • University of Alabama at Birmingham

    lead OTHER

Principal Investigators

  • Gabrielle B Rocque, MD · The University of Alabama at Birmingham

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-01
Primary Completion
2030-07-31
Completion
2031-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07671937 on ClinicalTrials.gov